Reimbursed Care Access in Cabo Verde

Currently classified as a strictly controlled substance under Cabo Verdean criminal and drug legislation with no authorized medical use outside of approved clinical research. The Cabo Verde Penal Code and related drug control provisions criminalize unauthorised possession, trafficking and distribution of narcotics and psychotropic substances; hallucinogens and similar psychotropic agents are treated under that framework, and there is no public evidence of a regulated, reimbursed medical pathway for psilocybin treatment in Cabo Verde. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research in Cabo Verde. MDMA (ecstasy) and other entactogens/hallucinogens are covered by the drug control provisions in the national Penal Code; there is no evidence of regulatory approval, clinical‑scale medical programs, or insurance reimbursement for MDMA‑assisted therapy in the country. #

No publicly available evidence was found indicating regulatory approval or a national reimbursement pathway for esketamine (Spravato® or equivalent esketamine nasal formulations) in Cabo Verde. While esketamine is an established, regulated medicine for treatment‑resistant depression in some jurisdictions, application and listing by Cabo Verde’s medicines regulator or Ministry of Health are not publicly documented in available sources; therefore esketamine is not known to be legally available as a reimbursed therapy in Cabo Verde and would not be considered part of standard public‑insurance covered care. Cabo Verde has a centralized medicines regulation framework and an independent health regulatory authority responsible for medicines and health product oversight, but I found no regulatory listing or reimbursement policy for esketamine in the publicly accessible records searched. # #

Ketamine is widely used globally as an anaesthetic and analgesic agent in hospital settings; Cabo Verde’s health regulatory framework includes oversight of medicines and clinical practice, and there is no indication in the available public records that ketamine is banned for legitimate medical use in the country. However, there is no documented, regulated program or national reimbursement pathway in Cabo Verde for ketamine when used specifically as an adjunct in psychedelic‑assisted psychotherapy (e.g., ketamine‑assisted psychotherapy for psychiatric indications) nor evidence of formal approval of ketamine for psychiatric indications under a reimbursed national benefit. In practice, ketamine as an anaesthetic is managed under standard medicine supply and hospital formularies regulated by national health authorities; any off‑label psychiatric uses would fall under clinicians’ prescribing discretion and institutional policies but would not be part of an established, publicly reimbursed psychedelic therapy program according to the sources located. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no publicly available regulatory approval or reimbursement framework for DMT or DMT‑based therapies in Cabo Verde. Possession, distribution or use outside authorised research contexts would be criminally actionable under the national drug control/penal provisions. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. No public evidence of a regulatory pathway, health‑system access or reimbursement for 5‑MeO‑DMT in Cabo Verde was identified in the sources consulted. Activities involving this compound outside approved clinical research would be subject to criminal penalties. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no regulatory approval or reimbursement mechanism for ibogaine in Cabo Verde; its use outside sanctioned clinical trials or authorised medical contexts would be illegal. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Although ayahuasca is a traditional plant‑based preparation and is used in ritual contexts in some countries, in Cabo Verde its active psychotropic components fall under the national controls on psychotropic substances and there is no registered medical or reimbursed therapeutic pathway. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mescaline (including peyote and related cacti containing mescaline) is treated under the national narcotics/psychotropic controls and there is no public evidence of medical authorization, clinical programme access, or reimbursement for mescaline‑based therapy in Cabo Verde. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. The 2C family (2C‑X) and related synthetic phenethylamine hallucinogens are listed among hallucinogens/psychotropic agents in drug control frameworks and are not part of any reimbursed medical program in Cabo Verde. Possession, manufacture or trafficking outside authorised research is criminalised. #